Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Atrial Fibrillation Drugs Market
Atrial Fibrillation Drugs Market Size
- Report ID: GMI3253
- Published Date: Apr 2019
- Report Format: PDF
Atrial Fibrillation Drugs Market Size
Atrial Fibrillation Drugs Market size was valued at USD 13 billion in 2018 and is expected to witness 3% CAGR from 2019 to 2025.
Atrial fibrillation drugs market is expected to witness lucrative growth over the forecast period. Increasing rate of geriatric population coupled with rising prevalence of valvular diseases will augment the market growth. Moreover, increasing rate of population suffering from diabetes is another factor fueling the growth of atrial fibrillation drugs market. Increasing prevalence of cardiovascular diseases in emerging regions owing to rise in sedentary lifestyle and increasing habit of binge eating will fuel adoption rates in developing as well as certain developed countries.
| Report Attribute | Details |
|---|---|
| Base Year: | 2018 |
| Atrial Fibrillation Drugs Market Size in 2018: | 13 Billion (USD) |
| Forecast Period: | 2019 to 2025 |
| Forecast Period 2019 to 2025 CAGR: | 3% |
| 2025 Value Projection: | 17 Billion (USD) |
| Historical Data for: | 2014 to 2018 |
| No. of Pages: | 350 |
| Tables, Charts & Figures: | 728 |
| Segments covered: | Products, Atrial Fibrillation Type, Application, Route of Administration, End-use and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
However, drug side effects will be one of the major reasons hindering the adoption rates in few developing and under-developed countries. Drug side effects such as severe bleeding, tiredness, etc. will continue to hamper market growth over the forecast timeframe. Also, lack of awareness about recent medical drug therapies for the treatment of atrial fibrillation in certain emerging regions might hamper the market growth.
Frequently Asked Questions (FAQ) :
Atrial Fibrillation Drugs Market Scope
